Chronic Myeloproliferative Disorders Terminated Phase Trials for Moxifloxacin (DB00218)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00062231Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerSupportive Care